Phesi digital twin analysis finds Type 2 diabetes one of top five most studied diseases globally

Increase in T2D research comes at time of rising interest in GLP-1s including Ozempic and Wegovy; global analysis also finds almost a third of all Phase II trials are canceled, signaling a continued upwards trend in attrition.